Found 48 matching trials
Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease PHASE2 The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Show More Location
Multiple Locations
Learn More & Join Trial
Selinexor, Cyclophosphamide and Prednisone in Myeloma PHASE2 The trial is designed as a randomised, controlled, open, parallel group, mu...
Show More Location
Birmingham Heartlands Hospital
Learn More & Join Trial
Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L PHASE2 The purpose of this study is to compare the effects, good and bad, of two w...
Show More Location
Memoral Sloan Kettering Cancer Center
Learn More & Join Trial
Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide PHASE2 Evaluation of the effect of nivolumab and daratumumab with or without low-d...
Show More Location
Rijnstate ziekenhuis
Learn More & Join Trial
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma PHASE1 Evaluation the safety,tolerability, preliminary efficacy,and PK/PD of KQ-20...
Show More Location
Hematology Department of ShanXi Cancer Hospital
Learn More & Join Trial
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia PHASE3 RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Show More Location
HealthOne Presbyterian St. Lukes Medical Center
Learn More & Join Trial
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. PHASE1 This research study is studying a novel type of CLL vaccine as a possible t...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers PHASE2 Background:
Patients with cancers of the blood and immune system often ben...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients PHASE2 The purpose of this study is to determine whether the association of Carfil...
Show More Location
IRCCS CROB UOC di Ematologia e trapianto cellule staminali Ospedale Oncologico Regionale
Learn More & Join Trial
Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation PHASE2 The investigators will conduct randomized and controlled clinical studies i...
Show More Learn More & Join Trial